A phase 2 study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation with pembrolizumab in patients with inoperable locally advanced or metastatic triple negative breast cancer Telli, M. L., Wapnir, I., Vinayak, S., Chang, J., Alemany, C., Twitty, C., Gargosky, S. AMER ASSOC CANCER RESEARCH. 2019

View details for DOI 10.1158/1538-7445.SABCS18-OT2-06-03

View details for Web of Science ID 000478677000137